BENJAMIN STRAHAN: Open Payments
NPI 1376174235 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 42 payments from 10 companies in 2025. Trend: 2023 $331 · 2024 $543 · 2025 $731
Food & beverage: $721Education: $10
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 23 | $342 |
| ABBVIE INC. | 8 | $160 |
| Laborie Medical Technologies Corp. | 3 | $79 |
| Endo USA, Inc. | 2 | $45 |
| 180 Medical, Inc. | 1 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| TOLMAR, INC. | 1 | $14 |
| Boston Scientific Corporation | 1 | $5 |
Products named: GEMTESA, BOTOX, AVEED, ADSTILADRIN, KEYTRUDA, LUPRON DEPOT, Xtandi, JATENZO.
Industry payments across TX — which companies pay providers there.
